AccessScan provides comprehensive, integrated services help pharmaceutical and biotech manufacturers maximize product access and commercialization across full product lifecycle.

The aim is to build differentiated and value-based product position, navigate barriers to access and, drive adherence through innovative patient and prescriber support tools.

Our market access services cover a throughout process of data collection analysis and consulting.

Our reimbursement and value demonstration services include evidence review and synthesis, data collection to populate economic models or to serve as stand-alone burden of illness or healthcare efficiency studies, health-economic analyses, adaptations and modelling studies, reimbursement dossier preparations and maneuvering all those through administrative processes.

While our patient support and education programs ensure fast market uptake of products and services after reimbursement.

We provide high quality real word data studies in wide range of areas such as health economics, outcomes research, epidemiology and registries, along with advanced technical and operational support, to provide full service, high quality evidence-gathering services.

Scan Group
Rybárska 1099/21
931 01 Šamorín

V.3.0 (Last Update: 2015.02.16.)
© Scan Group 2009-2014, Všetky práva vyhradené.